CERU: Cerulean Pharma Inc. - Summary | Jitta

Cerulean Pharma Inc.

NASDAQ:CERU

Notice
Stock data is unavailable or the company’s delisted.
Price
$3.77
Loss Chance
58.4%
1.80JITTA SCORE
n/a
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (45)
Recent Business Performance (60)
Financial Strength (0)
Return to Shareholders (0)
Competitive Advantage (4)
Jitta Signs
Recent IPOLess than 3 years
Operating MarginInconsistent
Recent Business PerformanceEarning decline 0.73% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.80
n/a
2.21
139.10%
COMPANY DESCRIPTION
As of July 19, 2017, Cerulean Pharma Inc. was acquired by Daré Bioscience, Inc., in a reverse merger transaction. Cerulean Pharma Inc. develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. It has a collaboration with Novartis Institutes for BioMedical Research, Inc. to develop nanoparticle-drug conjugates. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.